In the 4T1 tumor-bearing mouse model, after 1 h of administration, nanoparticles were rapidly taken in by tumor cells through the Tf-R mediated endocytosis pathway to exert anti-tumor effects. This evidence concerns the gene TFRC and neoplasm.